Skip to main content

Table 1 Patient characteristics

From: Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial

  Overall (n=57) GnRH (n=22) DNG (n=27) P value
Age [years] 33.0 ± 5.6 33.0 ± 5.7 33.0 ± 5.5 0.83 a
Cyst size [cm] 7 [5-8] 5.5 [4.6-8] 7 [5.2-8] 0.26 b
Surgery     
Unilateral / Bilateral
[n (%)]
34 (59) / 23 (41) 12 (54) / 10 (45) 17 (62) / 10 (38) 0.57 c
rASRM score 57 [36-78] 48 [37-64] 63 [37-85] 0.35 b
Operation time [min] 130 ± 39 123 ± 38 135 ± 39 0.28 a
Blood loss [ml] 51 [4.5-204] 50 [4.5-138] 95 [8.5-216] 0.31 b
Total time of use of hemostasis [s] 16 ± 10 12 ± 8.9 18 ± 10 0.32 a
Patient number of resection of follicles in specimens
[n (%)]
21 (40) 8 (36) 13 (43) 0.77 d
Serum FSH [mlU/mL]     
pre-treatment 6.0 [4.8-7.2] 5.8 [4.9-8.4] 6.2 [4.5-6.9] 0.81 b
postoperative 2 month (4 M) 5.8 [3.9-7.1] 4.8 [3.1-5.7] 6.6 [4.5-7.2] 0.018 b
postoperative 6 month (8 M) 5.7 [4.8-9.0] 4.6 [3.8-10.2] 5.5 [4.9-7.4] 0.64 b
postoperative 1 year
(14 M)
6.5 [4.2-7.9] 8.5 [6.7-11.4] 5.9 [3.8-9.1] 0.014 b
Serum AMH [ng/mL]     
pre-treatment 2.3 [1.1-3.8] 2.3 [1.1-4.0] 2.2 [1.1-3.2] 0.54 b
postoperative 2 month (4 M) 1.5 [0.63-2.0] 1.5 [0.84-2.1] 1.3 [0.54-2.0] 0.43 b
postoperative 6 month (8 M) 1.1 [0.56-2.0] 1.0 [0.68-2.1] 1.2 [0.42-2.0] 0.69 b
postoperative 1 year
(14 M)
1.0 [0.50-2.3] 0.79 [0.48-2.2] 1.3 [0.64-2.7] 0.10 b
  Overall (n=32) GnRH (n=15) DNG (n=17) P value
Pregnancy [n (%)] 10 (31) 6 (40) 4 (23) 0.45 d
  1. Note: The values are presented as the mean ± standard division (SD) or median [25th, 75th percentile]
  2. a. Student’s t-test
  3. b. Mann-Whitney U test
  4. c. Chi-square test
  5. d. Fisher’s exact test